6 results  1 of 1 

1 A Case of Corneal Opacity Improved by Treatment of Demodex Blepharitis
Jung Huh, Kyoung Woo Kim, Jae Chan Kim
J Korean Ophthalmol Soc.2014;55(10):1558-1561.   Published online 2014 October 15     DOI: http://dx.doi.org/10.3341/jkos.2014.55.10.1558
      
2 Biometric Risk Factors for Corneal Neovascularization Associated with Hydrogel Soft Contact Lens Wear in Korean Myopic Patients
Dae Seung Lee, Mee Kum Kim, Won Ryang Wee
Korean J Ophthalmol.2014;28(4):292-297.   Published online 2014 July 22     DOI: http://dx.doi.org/10.3341/kjo.2014.28.4.292
      
3 Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung
Korean J Ophthalmol.2014;28(2):177-180.   Published online 2014 March 14     DOI: http://dx.doi.org/10.3341/kjo.2014.28.2.177
      
4 The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
Jin-Hyoung Kim, Hae-Won Seo, Hyun-Cheol Han, Jong-Hyun Lee, Suk-Kyue Choi, Doh Lee
Korean J Ophthalmol.2013;27(4):235-242.   Published online 2013 July 5     DOI: http://dx.doi.org/10.3341/kjo.2013.27.4.235
      
5 The Effects of a Subtenoncapsular Injection of Bevacizumab for Ocular Surface Disease With Corneal Neovascularization
Jae Hoon Jeong, Yeoun Sook Chun, Jae Chan Kim
J Korean Ophthalmol Soc.2009;50(10):1475-1482.   Published online 2009 October 23     DOI: http://dx.doi.org/10.3341/jkos.2009.50.10.1475
      
6 Treatment of corneal neovascularization with argon laser
Kyung Jik Lim, Won Ryang Wee, Jin Hak Lee
Korean J Ophthalmol.1993;7(1):25-27.   Published online 1993 June 30     DOI: http://dx.doi.org/10.3341/kjo.1993.7.1.25
   

 1 of 1